183 related articles for article (PubMed ID: 29220492)
1. HBV-Derived Synthetic Long Peptide Can Boost CD4+ and CD8+ T-Cell Responses in Chronic HBV Patients Ex Vivo.
Dou Y; van Montfoort N; van den Bosch A; de Man RA; Zom GG; Krebber WJ; Melief CJM; Buschow SI; Woltman AM
J Infect Dis; 2018 Feb; 217(5):827-839. PubMed ID: 29220492
[TBL] [Abstract][Full Text] [Related]
2. Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patients.
Dou Y; Jansen DTSL; van den Bosch A; de Man RA; van Montfoort N; Araman C; van Kasteren SI; Zom GG; Krebber WJ; Melief CJM; Woltman AM; Buschow SI
Antiviral Res; 2020 Jun; 178():104746. PubMed ID: 32081741
[TBL] [Abstract][Full Text] [Related]
3. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
[TBL] [Abstract][Full Text] [Related]
4. Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
Boni C; Janssen HLA; Rossi M; Yoon SK; Vecchi A; Barili V; Yoshida EM; Trinh H; Rodell TC; Laccabue D; Alfieri A; Brillo F; Fisicaro P; Acerbi G; Pedrazzi G; Andreone P; Cursaro C; Margotti M; Santoro R; Piazzolla V; Brunetto MR; Coco B; Cavallone D; Zhao Y; Joshi A; Woo J; Lau AH; Gaggar A; Subramanian GM; Massetto B; Fung S; Ahn SH; Ma X; Mangia A; Ferrari C
Gastroenterology; 2019 Jul; 157(1):227-241.e7. PubMed ID: 30930022
[TBL] [Abstract][Full Text] [Related]
5. Lentiviral vector encoding ubiquitinated hepatitis B core antigen induces potent cellular immune responses and therapeutic immunity in HBV transgenic mice.
Dai S; Zhuo M; Song L; Chen X; Yu Y; Zang G; Tang Z
Immunobiology; 2016 Jul; 221(7):813-21. PubMed ID: 26874581
[TBL] [Abstract][Full Text] [Related]
6. Induction of broad multifunctional CD8+ and CD4+ T cells by hepatitis B virus antigen-based synthetic long peptides
Jansen DTSL; de Beijer MTA; Luijten RJ; Kwappenberg K; Wiekmeijer AS; Kessler AL; Pieterman RFA; Bouzid R; Krebber WJ; de Man RA; Melief CJM; Buschow SI
Front Immunol; 2023; 14():1163118. PubMed ID: 37781393
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro.
Shi M; Qian S; Chen WW; Zhang H; Zhang B; Tang ZR; Zhang Z; Wang FS
Clin Exp Immunol; 2007 Feb; 147(2):277-86. PubMed ID: 17223969
[TBL] [Abstract][Full Text] [Related]
8. Activated plasmacytoid dendritic cells act synergistically with hepatitis B core antigen-pulsed monocyte-derived dendritic cells in the induction of hepatitis B virus-specific CD8 T-cell response.
Chen W; Zhang Z; Shi M; Chen L; Fu J; Shi F; Zhang B; Zhang H; Jin L; Wang FS
Clin Immunol; 2008 Nov; 129(2):295-303. PubMed ID: 18774748
[TBL] [Abstract][Full Text] [Related]
9. Restoration in vitro of impaired T-cell responses in patients with chronic hepatitis B by autologous dendritic cells loaded with hepatitis B virus proteins (R2).
Duan XZ; He HX; Zhuang H
J Gastroenterol Hepatol; 2006 Jun; 21(6):970-6. PubMed ID: 16724980
[TBL] [Abstract][Full Text] [Related]
10. HBcAg18-27 epitope fused to HIV-Tat 49-57 adjuvanted with CpG ODN induces immunotherapeutic effects in transgenic mice.
Wang S; Han Q; Zhang N; Chen J; Liu Z; Zhang G; Li Z
Immunol Lett; 2010 Jan; 127(2):143-9. PubMed ID: 19883689
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells from chronic hepatitis B patients can induce HBV antigen-specific T cell responses.
Li RB; Chen HS; Xie Y; Fei R; Cong X; Jiang D; Wang SX; Wei L; Wang Y
World J Gastroenterol; 2004 Jun; 10(11):1578-82. PubMed ID: 15162529
[TBL] [Abstract][Full Text] [Related]
12. Recognition of Core- and Polymerase-derived immunogenic peptides included in novel therapeutic vaccine by T cells from Chinese chronic hepatitis B patients.
Huang D; Sansas B; Jiang JH; Gong QM; Jin GD; Calais V; Yu DM; Zhu MY; Wei D; Zhang DH; Inchauspé G; Zhang XX; Zhu R
J Viral Hepat; 2017 Nov; 24 Suppl 1():66-74. PubMed ID: 29082648
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus-specific T-cell responses during IFN administration in a small cohort of chronic hepatitis B patients under nucleos(t)ide analogue treatment.
Sprinzl MF; Russo C; Kittner J; Allgayer S; Grambihler A; Bartsch B; Weinmann A; Galle PR; Schuchmann M; Protzer U; Bauer T
J Viral Hepat; 2014; 21(9):633-41. PubMed ID: 24251783
[TBL] [Abstract][Full Text] [Related]
14. Activation of CD4 T cells during prime immunization determines the success of a therapeutic hepatitis B vaccine in HBV-carrier mouse models.
Su J; Brunner L; Ates Oz E; Sacherl J; Frank G; Kerth HA; Thiele F; Wiegand M; Mogler C; Aguilar JC; Knolle PA; Collin N; Kosinska AD; Protzer U
J Hepatol; 2023 Apr; 78(4):717-730. PubMed ID: 36634821
[TBL] [Abstract][Full Text] [Related]
15. TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice.
Martin P; Dubois C; Jacquier E; Dion S; Mancini-Bourgine M; Godon O; Kratzer R; Lelu-Santolaria K; Evlachev A; Meritet JF; Schlesinger Y; Villeval D; Strub JM; Van Dorsselaer A; Marchand JB; Geist M; Brandely R; Findeli A; Boukhebza H; Menguy T; Silvestre N; Michel ML; Inchauspé G
Gut; 2015 Dec; 64(12):1961-71. PubMed ID: 25429051
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection.
Nebbia G; Peppa D; Schurich A; Khanna P; Singh HD; Cheng Y; Rosenberg W; Dusheiko G; Gilson R; ChinAleong J; Kennedy P; Maini MK
PLoS One; 2012; 7(10):e47648. PubMed ID: 23112829
[TBL] [Abstract][Full Text] [Related]
17. Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen.
Lau GK; Suri D; Liang R; Rigopoulou EI; Thomas MG; Mullerova I; Nanji A; Yuen ST; Williams R; Naoumov NV
Gastroenterology; 2002 Mar; 122(3):614-24. PubMed ID: 11874993
[TBL] [Abstract][Full Text] [Related]
18. A novel T-cell epitope in the transmembrane region of the hepatitis B virus envelope protein responds upon dendritic cell expansion.
Chen L; Zhang Y; Zhang S; Chen Y; Shu X; Lai J; Cao H; Lian Y; Stamataki Z; Huang Y
Arch Virol; 2019 Feb; 164(2):483-495. PubMed ID: 30415392
[TBL] [Abstract][Full Text] [Related]
19. In vitro use of autologous dendritic cells improves detection of T cell responses to hepatitis B virus (HBV) antigens.
Carotenuto P; Artsen A; Niesters HG; Osterhaus AD; Pontesilli O
J Med Virol; 2009 Feb; 81(2):332-9. PubMed ID: 19107973
[TBL] [Abstract][Full Text] [Related]
20. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
Akbar SM; Chen S; Al-Mahtab M; Abe M; Hiasa Y; Onji M
Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
